Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Short-term Investments (2016 - 2025)

Healthcare Services (HCSG) has disclosed Short-term Investments for 17 consecutive years, with $42.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-term Investments rose 70.38% to $42.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $42.8 million, a 70.38% increase, with the full-year FY2025 number at $42.8 million, up 70.38% from a year prior.
  • Short-term Investments was $42.8 million for Q4 2025 at Healthcare Services, up from $30.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $125.8 million in Q2 2021 to a low of $25.1 million in Q3 2024.
  • A 5-year average of $79.7 million and a median of $93.2 million in 2023 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: plummeted 73.04% in 2024, then skyrocketed 70.38% in 2025.
  • Healthcare Services' Short-term Investments stood at $114.4 million in 2021, then decreased by 16.78% to $95.2 million in 2022, then fell by 2.17% to $93.1 million in 2023, then tumbled by 73.04% to $25.1 million in 2024, then surged by 70.38% to $42.8 million in 2025.
  • Per Business Quant, the three most recent readings for HCSG's Short-term Investments are $42.8 million (Q4 2025), $30.0 million (Q3 2025), and $29.3 million (Q2 2025).